PFIZER INCPFE
時価総額
$1423.6億
PER
研究開発型グローバルバイオ医薬品の最大手（1942年6月設立）。ワクチンや医薬品（Comirnaty、Paxlovid等）を展開。2022年にBiohavenを約118億ドルで買収、同年にArenaを約66億ドルで買収。約200カ国・地域に供給。
| 2010年 12月31日 | 2011年 12月31日 | 2012年 12月31日 | 2013年 12月31日 | 2014年 12月31日 | 2015年 12月31日 | 2016年 12月31日 | 2017年 12月31日 | 2018年 12月31日 | 2019年 12月31日 | 2020年 12月31日 | 2021年 12月31日 | 2022年 12月31日 | 2023年 12月31日 | 2024年 12月31日 | |
| Net income before allocation to noncontrolling interests | 8,289 | 10,051 | 14,598 | 22,072 | 9,168 | 6,986 | 7,246 | 21,355 | 11,188 | 16,302 | 9,652 | 22,025 | 31,407 | 2,158 | 8,062 |
| Discontinued operations––net of tax | -9 | 1,312 | 5,080 | 10,662 | 48 | 11 | 17 | 2 | 10 | 4 | 2,631 | -434 | 6 | -15 | 11 |
| Net income from continuing operations before allocation to noncontrolling interests | 8,298 | 8,739 | 9,518 | 11,410 | 9,119 | 6,975 | 7,229 | 21,353 | 11,179 | 16,298 | 7,021 | 22,459 | 31,401 | 2,172 | 8,051 |
| Depreciation and amortization | 8,487 | 9,026 | 7,611 | - | - | - | - | - | - | - | - | - | - | 6,290 | 7,013 |
| Asset write-offs and impairments | - | - | - | - | 531 | 1,119 | 1,613 | 634 | 3,398 | 2,953 | 2,049 | 276 | 550 | 3,408 | 4,242 |
| Deferred taxes | 1,953 | 264 | 739 | 1,726 | 320 | -20 | -700 | -2,410 | -2,205 | 614 | -1,468 | -4,293 | -3,764 | -3,442 | -2,102 |
| Share-based compensation expense | 405 | 419 | 481 | 523 | 586 | 669 | 691 | 840 | 949 | 718 | 756 | 1,182 | 872 | 525 | 877 |
| Benefit plan contributions in excess of expense/income | - | - | - | - | 199 | 617 | 712 | 961 | 1,095 | 336 | 1,790 | 3,123 | 1,158 | 787 | 12 |
| Inventory Write-down | - | - | - | - | - | - | - | - | - | - | - | - | - | 6,199 | - |
| Other adjustments, net | - | 189 | -203 | 324 | 430 | 160 | -209 | -50 | 1,268 | 1,086 | 478 | 1,573 | -758 | 3,492 | 2,260 |
| Trade accounts receivable | 608 | 66 | -275 | -940 | -148 | -21 | 134 | -259 | 644 | 742 | 1,249 | 3,811 | -261 | -347 | 109 |
| Inventories | -2,917 | -1,084 | 631 | 538 | -175 | 199 | -365 | 357 | 717 | 1,050 | 736 | 1,125 | -592 | 1,200 | 854 |
| Other assets | 896 | -582 | -83 | 822 | -1,156 | -249 | 60 | 31 | 16 | -795 | 146 | 1,057 | 4,506 | 663 | -3,380 |
| Trade accounts payable | - | - | - | - | - | 254 | 871 | 46 | 431 | -564 | 353 | 1,242 | 1,191 | -300 | -1,023 |
| Other liabilities | - | - | -3,438 | -3,184 | -844 | 474 | -223 | -67 | 98 | 267 | 2,741 | 18,721 | -1,449 | 595 | -3,115 |
| Other tax accounts, net | - | - | - | - | 491 | -235 | -734 | 1,446 | -78 | -2,737 | -1,238 | -1,166 | -545 | -982 | -1,345 |
| Net cash provided by/(used in) operating activities | 11,454 | 20,240 | 17,054 | 17,765 | 16,883 | 14,512 | 15,901 | 16,470 | 15,827 | 12,588 | 14,403 | 32,580 | 29,267 | 8,700 | 12,744 |
| Purchases of property, plant and equipment | 1,513 | 1,660 | 1,327 | 1,206 | 1,199 | 1,397 | 1,823 | 1,956 | 2,042 | 2,176 | 2,252 | 2,711 | 3,236 | 3,907 | 2,909 |
| Purchases of short-term investments | 10,931 | 18,428 | 24,018 | 42,761 | 50,954 | 28,581 | 15,957 | 14,596 | 11,677 | 6,835 | 13,805 | 38,457 | 36,384 | 30,974 | 10,133 |
| Proceeds from redemptions/sales of short-term investments | - | 13,615 | 25,302 | 41,127 | 47,374 | 40,064 | 29,436 | 10,307 | 17,581 | 9,183 | 11,087 | 27,447 | 44,821 | 39,264 | 4,128 |
| Net (purchases of)/proceeds from redemptions/sales of short-term investments with original maturities of three months or less | - | - | - | - | - | - | - | - | - | - | -920 | 8,088 | 483 | -5,174 | -3,136 |
| Purchases of long-term investments | 3,920 | 4,063 | 11,145 | 11,020 | 10,718 | 9,542 | 8,011 | 3,537 | 1,797 | 201 | 597 | 1,068 | 1,913 | 204 | 180 |
| Proceeds from redemptions/sales of long-term investments | - | 2,147 | 4,990 | 7,555 | 6,145 | 6,929 | 11,254 | 3,594 | 6,244 | 232 | 723 | 649 | 641 | 1,979 | 1,570 |
| Proceeds from Sale of Equity Method Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 7,040 |
| Acquisitions of businesses, net of cash acquired | 273 | 3,282 | 1,050 | 15 | 195 | 16,466 | 18,368 | 1,000 | - | 10,861 | - | - | 22,997 | 43,430 | - |
| Dividend received from the Consumer Healthcare JV | - | - | - | - | - | - | - | - | - | - | - | - | 3,960 | - | - |
| Other investing activities, net | -118 | -279 | -93 | -231 | -347 | -344 | -51 | -650 | -288 | -205 | -274 | 305 | 192 | 179 | -2 |
| Net cash provided by/(used in) investing activities | -492 | 2,200 | 6,154 | -10,625 | -5,654 | -2,980 | -7,811 | -4,741 | 4,525 | -3,945 | -4,271 | -22,546 | -15,783 | -32,278 | 2,652 |
| Proceeds from Short-Term Debt | - | - | - | 4,323 | 13 | 5,557 | 7,472 | 8,464 | 3,711 | 16,455 | 12,352 | - | 3,891 | 4,525 | 8,907 |
| Payments on short-term borrowings | - | - | - | 4,234 | 10 | 3,965 | 5,102 | 9,990 | 4,437 | 8,378 | 22,197 | - | 3,887 | 3 | 11,226 |
| Proceeds from (Repayments of) Short-Term Debt, Maturing in Three Months or Less | - | -7,540 | -8,204 | 3,475 | -1,841 | 2,717 | -3,084 | 1,401 | -1,617 | 2,551 | -4,129 | -96 | -222 | 3,161 | -2,590 |
| Proceeds from issuance of long-term debt | - | 1 | - | 6,618 | 4,491 | - | 10,976 | 5,274 | 4,974 | 4,942 | 5,222 | 997 | - | 30,831 | - |
| Payments on long-term debt | 6 | 6,986 | 1,513 | 4,146 | 2,104 | 3,003 | 7,689 | 6,154 | 3,566 | 6,806 | 4,003 | 2,004 | 3,298 | 2,569 | 2,250 |
| Purchases of common stock | 1,000 | 9,000 | 8,228 | 16,290 | 5,000 | 6,160 | 5,000 | 5,000 | 12,198 | 8,865 | - | - | 2,000 | - | - |
| Cash dividends paid | 6,088 | 6,234 | 6,534 | 6,580 | 6,609 | 6,940 | 7,317 | 7,659 | 7,978 | 8,043 | 8,440 | 8,729 | 8,983 | 9,247 | 9,512 |
| Other financing activities, net | 66 | 168 | 488 | 109 | 72 | 298 | -196 | -233 | -588 | -736 | -869 | 16 | -335 | -631 | -469 |
| Net cash provided by/(used in) financing activities | -11,174 | -20,607 | -15,999 | -14,975 | -9,986 | -10,233 | -8,921 | -13,035 | -20,441 | -8,485 | -9,649 | -9,816 | -14,834 | 26,066 | -17,140 |
| Effect of exchange-rate changes on cash and cash equivalents and restricted cash and cash equivalents | - | - | - | - | - | - | - | - | -116 | -32 | -8 | -59 | -165 | -40 | -66 |
| Net increase/(decrease) in cash and cash equivalents and restricted cash and cash equivalents | - | - | - | - | - | - | - | - | -205 | 125 | 475 | 159 | -1,515 | 2,448 | -1,810 |
| Income taxes | 11,775 | - | 2,430 | 2,874 | 2,100 | 2,383 | 2,521 | 2,489 | 3,655 | 3,664 | 3,153 | 7,427 | 7,867 | 3,147 | 3,605 |
| Interest paid | - | - | 1,873 | 1,729 | 1,550 | 1,302 | 1,451 | 1,518 | 1,311 | 1,587 | 1,641 | 1,467 | 1,442 | 2,215 | 3,227 |
| Interest rate hedges | - | - | - | - | - | - | - | - | - | - | - | - | 54 | 134 | 178 |
| Right-of-use assets obtained in exchange for lease liabilities | - | - | - | - | - | - | - | - | - | - | - | 1,943 | 752 | 614 | 283 |